Notes: January 14, 2020 -- the Board determined to set the Reverse Stock Split ratio at one-for-ten (1:10) and approved the final form of the Certificate of Amendment to the Certificate of Incorporation to effectuate the Reverse Stock Split. The Common Stock is expected to begin trading on The Nasdaq Capital Market (“Nasdaq”) on an adjusted basis on Wednesday, January 15, 2020. There will be no change in the Company’s Nasdaq ticker symbol, “IDXG”. In connection with the Reverse Stock Split, the CUSIP number for the Common Stock has been changed to 46062X303. At the Effective Time, every ten (10) shares of Common Stock issued and outstanding will be automatically combined into one (1) share of issued and outstanding Common Stock, without any change in the par value per share. ________________ December 29, 2016 -- Interpace Diagnostics Group, Inc. (IDXG) will effect a one for ten (1 for 10) reverse split of its outstanding common stock. The CUSIP number will change to 46062X204.